OASIS-C
01/27/2022
Recent CMS guidance on how to answer M2020 (Management of oral medications) and M2030 (Management of injectable medications) represents a shift from previous guidance.
01/06/2022
Check out this OASIS Q&A with answers provided by Karen Tibbs, RN, MS, HCS-D, COS-C, quality manager OASIS and coding with McBee Associates.
12/29/2021
Agencies should start educating staff now and not wait until the last minute to prepare for the upcoming implementation of OASIS-E on Jan. 1, 2023.
12/09/2021
Use these scenarios related to GG0130A (Eating) to quiz your clinicians and ensure accuracy and compliance.
11/11/2021
Following a two-year delay in implementation due to the COVID-19 public health emergency (PHE), OASIS-E will be required for assessments beginning Jan. 1, 2023.
04/08/2021
To really move the needle on 5-star ratings, leaders should meet with clinicians who are conducting OASIS assessments at key points including start of care, resumption of care, discharge or transfer.
02/05/2020
Whether to transfer a patient with a discharge or without discharge has been causing much confusion among agencies in wake of the Patient-Driven Groupings Model (PDGM) implementation on Jan. 1.
11/27/2019
Reeducate clinicians on the definition of “clinically significant” to help improve accuracy and potentially save time when responding to M2001 (Drug regimen review) and M2003 (Medication follow-up).
07/24/2019
When responding to pressure ulcer items on the OASIS, clinicians can collaborate when only a partial skin assessment is completed on the first visit, according to the most recent release of CMS quarterly OASIS Q&As.
07/10/2019
Following a recent DecisionHealth webinar about addressing the key challenges clinicians face with OASIS-D, agencies asked questions of industry expert Karen Tibbs, quality and education manager with Wayne, Pa.-based McBee Associates.

Login

User Name:
Password: